Basel Medical Group Ltd (NASDAQ:BMGL)
| Market Cap | 3.05M-89.0% |
| Revenue (ttm) | 25.54M |
| Net Income | -614.22K |
| EPS | -0.85 |
| Shares Out | 1.58M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,510,944 |
| Open | 5.39 |
| Previous Close | 5.40 |
| Day's Range | 1.53 - 5.49 |
| 52-Week Range | 1.53 - 18.48 |
| Beta | 0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About BMGL
Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.
$BMGL stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in BMGL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BMGL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BMGL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BMGL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BMGL from public contracts
Source: USAspending.gov
BMGL Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from BMGL’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.